UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 21, 2015

STRAGENICS, INC.

(Exact Name of Registrant as Specified in Charter)

Florida

333-157565

46-5209647

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

100 Rialto Place, Suite 700, Melbourne, FL 32901

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (321-541-1216

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On September 11, 2015, Stragenics, Inc., (the “Company”) filed with the Secretary of State of Florida to amended its Articles of Incorporation (the ”Amendment”) to increase the total authorized shares of common stock, par value $.0001 (“Common Stock”) from 900,000,000 shares to 3,500,000,000. The Company received verification from the Secretary of State on September 18, 2015.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	STRAGENICS, INC.

Date: September 21, 2015	By:	/s/ Alan W. Grofe
		Alan W. Grofe
		Chief Executive Officer & President

STRAGENICS, INC. 8-K